Evidence map›Paper›PMID 28497341›Full record

ArticleNeurochemical research2017

Chronic TNFα Exposure Induces Robust Proliferation of Olfactory Ensheathing Cells, but not Schwann Cells.

Karen L Lankford, Edgardo J Arroyo, Jeffery D Kocsis

Abstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Glial cells in the mammalian olfactory bulb.Frontiers in cellular neuroscience · 2024
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Karen L LankfordDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Edgardo J ArroyoDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Jeffery D KocsisDepartment of Neurology, Yale University School of Medicine, New Haven, CT, USA. Jeffery.Kocsis@yale.edu.
Yale University · US

Funding

Therapeutic Potential of Mesenchymal Stem Cell-Derived Exosomes for Treatment of Contusive Spinal Cord InjuryI01BX003190 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI KOCSIS, JEFFERY D. · 2017 to 2020
–
BLRD VA I01 BX003190Connecticut (CT) Stem Cell Research Program 12-SCB-Yale-05National Multiple Sclerosis Society RG2135U.S. Department of Veterans Affairs B7335R, B9260L
6 · The paper itself

Abstract

TNFα is persistently elevated in many injury and disease conditions. Previous reports of cytotoxicity of TNFα for oligodendrocytes and their progenitors suggest that the poor endogenous remyelination in patients with traumatic injury or multiple sclerosis may be due in part to persistent inflammation. Understanding the effects of inflammatory cytokines on potential cell therapy candidates is therefore important for evaluating the feasibility of their use. In this study, we assessed the effects of long term exposure to TNFα on viability, proliferation, migration and TNFα receptor expression of cultured rat olfactory ensheathing cells (OECs) and Schwann cells (SCs). Although OECs and SCs transplanted into the CNS produce similar myelinating phenotypes, and might be expected to have similar therapeutic uses, we report that they have very different sensitivities to TNFα. OECs exhibited positive proliferative responses to TNFα over a much broader range of concentrations than SCs. Low TNFα concentrations increased proliferation and migration of both OECs and SCs, but SC number declined in the presence of 100 ng/ml or higher concentrations of TNFα. In contrast, OECs exhibited enhanced proliferation even at high TNFα concentrations (up to 1 µg/ml) and showed no evidence of TNF cytotoxicity even at 4 weeks post-treatment. Furthermore, while both OECs and SCs expressed TNFαR1 and TNFαR2, TNFα receptor levels were downregulated in OECs after exposure to100 ng/ml TNFα for 5-7 days, but were either elevated or unchanged in SCs. These results imply that OECs may be a more suitable cell therapy candidate if transplanted into areas with persistent inflammation.

Indexed as

AnimalsAxon GuidanceCell MovementCell ProliferationCells, CulturedDose-Response Relationship, DrugOlfactory BulbOlfactory MucosaRatsRats, TransgenicSchwann CellsTumor Necrosis Factor-alphaTumor Necrosis Factor-alphaMigrationOECs and Schwann cellsOlfactory ensheathing cellsProliferationTNFαTNFα receptor

Identifiers

PMID28497341
OpenAlexW2613893196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.